P-15L graft, a substitute for autologous bone, is based on synthetic small peptide technology and was developed to spur bone growth. Cerapedics has enrolled the first of 364 patients in this
Investigational Device Exemption clinical trial.
Companies are applying new manufacturing and surface processes to PEEK to overcome some of the material's limitations. HAPPE Spine is developing a material that allows for the construction of partial or fully-porous hydroxyapatite-reinforced PEEK implants.
Losing key employees hurts. Not only is it demoralizing to you, but it can have a ripple effect. When a company loses one of its best people, others may look elsewhere for their future rather than in their current company. What does a manager do to avoid this?